|
|
|
| Contribution of gut microbiota to drug-induced liver injury |
| Hui-Kuan Chu # , Yan Ai # , Zi-Lu Cheng # , Ling Yang, Xiao-Hua Hou ∗ |
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
∗Corresponding author.
E-mail address: houxh@hust.edu.cn (X.-H. Hou).
# Contributed equally. |
|
|
|
|
Abstract Drug-induced liver injury (DILI) is caused by various drugs with complex pathogenesis, and diverse clinical and pathological phenotypes. Drugs damage the liver directly through drug hepatotoxicity, or indirectly through drug-mediated oxidative stress, immune injury and inflammatory insult, which eventually lead to hepatocyte necrosis. Recent studies have found that the composition, relative content and distribution of gut microbiota in patients and animal models of DILI have changed significantly. It has been confirmed that gut microbial dysbiosis brings about intestinal barrier destruction and microorganisms translocation, and the alteration of microbial metabolites may cause or aggravate DILI. In addition, antibiotics, probiotics, and fecal microbiota transplantation are all emerging as prospective therapeutic methods for DILI by regulating the gut microbiota. In this review, we discussed how the altered gut microbiota participates in DILI.
|
|
|
|
|
|
|
|
|
2023, Vol. 22 
